Literature DB >> 18781258

Optical coherence tomography of the anterior segment.

Trefford Simpson1, Desmond Fonn.   

Abstract

Perhaps no diagnostic technology has emerged as rapidly in ophthalmology as optical coherence tomography (OCT). A single clinical device for this noninvasive imaging technique was first released in 1996, and now at least ten clinical devices are available. Although the first clinical anterior segment OCT was marketed only 2 years ago, a substantial amount of work has been done using modified retinal imagers or prototype laboratory-based imagers. In this review, we discuss OCT imaging primarily of the cornea. We also highlight previous and current publications on nonclinical and clinical uses of the device to illustrate how anterior segment OCT can be used to understand corneal structure and function in health and disease.

Mesh:

Year:  2008        PMID: 18781258     DOI: 10.1016/s1542-0124(12)70280-x

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  15 in total

Review 1.  In vivo imaging of corneal inflammation: new tools for clinical practice and research.

Authors:  Dimosthenis Mantopoulos; Andrea Cruzat; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2010 Sep-Nov       Impact factor: 1.975

2.  Evaluation of anterior chamber parameters with spectral-domain optical coherence tomography.

Authors:  Isabel Pinilla Lozano; Carmen López de la Fuente; Francisco Segura; Elvira Orduna Hospital; Ana Sánchez-Cano
Journal:  Jpn J Ophthalmol       Date:  2017-11-29       Impact factor: 2.447

Review 3.  New approaches for diagnosis of dry eye disease.

Authors:  Abdelrahman M Elhusseiny; Ali A Khalil; Reem H El Sheikh; Mohammad A Bakr; Mohamed Gaber Eissa; Yasmine M El Sayed
Journal:  Int J Ophthalmol       Date:  2019-10-18       Impact factor: 1.779

4.  Real-time cancer diagnosis during prostate biopsy: ex vivo evaluation of full-field optical coherence tomography (FFOCT) imaging on biopsy cores.

Authors:  Jonathan Lopater; Pierre Colin; Frédéric Beuvon; Mathilde Sibony; Eugénie Dalimier; François Cornud; Nicolas Barry Delongchamps
Journal:  World J Urol       Date:  2015-06-23       Impact factor: 4.226

5.  Use of High-Resolution Optical Coherence Tomography in the Surgical Management of Ocular Surface Squamous Neoplasia: A Pilot Study.

Authors:  Carol L Karp; Carolina Mercado; Nandini Venkateswaran; Marco Ruggeri; Anat Galor; Armando Garcia; Kavitha R Sivaraman; Maria Paula Fernandez; Antonio Bermudez; Sander R Dubovy
Journal:  Am J Ophthalmol       Date:  2019-06-01       Impact factor: 5.258

Review 6.  Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia.

Authors:  Benjamin J Thomas; Anat Galor; Afshan A Nanji; Fouad El Sayyad; Jianhua Wang; Sander R Dubovy; Madhura G Joag; Carol L Karp
Journal:  Ocul Surf       Date:  2013-11-09       Impact factor: 5.033

Review 7.  Imaging Techniques in the Diagnosis and Management of Ocular Tumors: Prospects and Challenges.

Authors:  Rabin Neupane; Ripal Gaudana; Sai H S Boddu
Journal:  AAPS J       Date:  2018-09-05       Impact factor: 4.009

8.  Role of high resolution optical coherence tomography in diagnosing ocular surface squamous neoplasia with coexisting ocular surface diseases.

Authors:  Marwan Atallah; Madhura Joag; Anat Galor; Guillermo Amescua; Afshan Nanji; Jianhua Wang; Victor L Perez; Sander Dubovy; Carol L Karp
Journal:  Ocul Surf       Date:  2017-03-24       Impact factor: 6.268

9.  Evaluation of Corneal Epithelial Healing Under Contact Lens with Spectral-Domain Anterior Segment Optical Coherence Tomography (SD-OCT).

Authors:  Claudine E Pang; Vanathi M; Donald T H Tan; Jodhbir S Mehta
Journal:  Open Ophthalmol J       Date:  2011-06-01

10.  Use of fourier-domain optical coherence tomography to evaluate anterior stromal opacities in donor corneas.

Authors:  Matthew R Bald; Christopher Stoeger; Joshua Galloway; Maolong Tang; Jeffrey Holiman; David Huang
Journal:  J Ophthalmol       Date:  2013-03-28       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.